Predicted protein targets (top 2)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ERBB2 | P04626 | 20/20 | 1.00 |
| ▸ | EGFR | P00533 | 1/20 | 0.83 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL19181047 | 1.00 | ERBB2 (1.00) | ERBB2EGFR | |
| SCHEMBL19181048 | 1.00 | ERBB2 (1.00) | ERBB2EGFR | |
| SCHEMBL20357519 | 0.96 | ERBB2 (1.00) | ERBB2EGFR | |
| SCHEMBL20357520 | 0.96 | ERBB2 (1.00) | ERBB2EGFR | |
| SCHEMBL19181013 | 0.91 | ERBB2 (1.00) | ERBB2EGFR | |
| SCHEMBL29434938 | 0.91 | ERBB2 (1.00) | ERBB2EGFR | |
| SCHEMBL29926978 | 0.91 | ERBB2 (1.00) | ERBB2EGFR | |
| SCHEMBL19181012 | 0.91 | ERBB2 (1.00) | ERBB2EGFR | |
| SCHEMBL19181638 | 0.90 | ERBB2 (1.00) | ERBB2EGFR | |
| SCHEMBL19181637 | 0.90 | ERBB2 (1.00) | ERBB2EGFR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3590516-B1 | ANTITUMOR-EFFECT ENHANCER USING PYRAZOLO[3,4-D]PYRIMIDINE COMPOUND | TAIHO PHARMACEUTICAL CO LTD (JP) | 2025-09-03 | — | — | EP | claimed |
| EP-3845231-B1 | THERAPEUTIC AGENT CONTAINING PYRAZOLO[3,4-D]PYRIMIDINE COMPOUND AS ACTIVE INGREDIENT | TAIHO PHARMACEUTICAL CO LTD (JP) | 2025-01-01 | — | — | EP | claimed |
| EP-3845231-B1 | THERAPEUTIC AGENT CONTAINING PYRAZOLO[3,4-D]PYRIMIDINE COMPOUND AS ACTIVE INGREDIENT | TAIHO PHARMACEUTICAL CO LTD (JP) | 2025-01-01 | — | — | EP | disclosed |